In 2002, 28 non-duplicate enterobacterial isolates producing extended-spectrum β-lactamases (ESBLs) were collected from infected patients at the Bicêtre Hospital in Paris, France. Escherichia coli was the predominant ESBL-positive enterobacterial species, comprising ten (36%) of the isolates. CTX-M enzymes (CTX-M-3, CTX-M-10, CTX-M-14 and CTX-M-15) were produced by 11 (39%) of the isolates (six E. coli, two Enterobacter cloacae, one Enterobacter aerogenes, one Proteus mirabilis and one Citrobacter freundii). Other ESBLs, such as VEB-1 and PER-1, were also detected, but less frequently. © 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Lartigue, M. F., Fortineau, N., & Nordmann, P. (2005). Spread of novel expanded-spectrum β-lactamases in enterobacteriaceae in a university hospital in the Paris area, France. Clinical Microbiology and Infection, 11(7), 588–591. https://doi.org/10.1111/j.1469-0691.2005.01172.x
Mendeley helps you to discover research relevant for your work.